LAURA LAI: Open Payments
NPI 1306874532 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 17 payments from 5 companies in 2025. Trend: 2023 $720 · 2024 $549 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $140 |
| Otsuka America Pharmaceutical, Inc. | 4 | $102 |
| Axsome Therapeutics, Inc. | 3 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Tris Pharma Inc | 2 | $38 |
Products named: VRAYLAR, REXULTI, Auvelity, TRINTELLIX, Dyanavel XR.
Industry payments across CA — which companies pay providers there.
